Search research articles
Contact Us
Filters
Showing results (151-160 of 6,083) with videos related to
Page
of 609
Sort By:
The Prostate
|
December 14, 2006
BXL-628, a vitamin D receptor agonist effective in benign prostatic hyperplasia treatment, prevents RhoA activation and inhibits RhoA/Rho kinase signaling in rat and human bladder
Annamaria Morelli, Linda Vignozzi, Sandra Filippi, et al.
The Prostate
|
March 21, 2007
Suggestive genetic linkage to chromosome 11p11.2-q12.2 in hereditary prostate cancer families with primary kidney cancer
Bo Johanneson, Kerry Deutsch, Laura McIntosh, et al.
The Prostate
|
March 22, 2007
Interleukin-6 undergoes transition from growth inhibitor associated with neuroendocrine differentiation to stimulator accompanied by androgen receptor activation during LNCaP prostate cancer cell progression
Soo Ok Lee, Jae Yeon Chun, Nagalakshmi Nadiminty, et al.
The Prostate
|
March 22, 2007
Characterization of the RSL1-dependent conditional expression system in LNCaP prostate cancer cells and development of a single vector format
Julie Lessard, Sonia Ben Aicha, Andréa Fournier, et al.
The Prostate
|
March 8, 2007
Frequency and number of neuroendocrine tumor cells in prostate cancer: no difference between radical prostatectomy specimens from patients with and without neoadjuvant hormonal therapy
Shinichiro Shimizu, Jiro Kumagai, Yoshinobu Eishi, et al.
The Prostate
|
March 8, 2007
Sonic and desert hedgehog signaling in human fetal prostate development
Guodong Zhu, Haiyen E Zhau, Hui He, et al.
The Prostate
|
March 8, 2007
Non-steroidal antiandrogens act as AF-1 agonists under conditions of high androgen-receptor expression
Hiroaki Fuse, Shigeru Korenaga, Matomo Sakari, et al.
The Prostate
|
March 8, 2007
Non-invasive bioluminescent detection of prostate cancer growth and metastasis in a bigenic transgenic mouse model
Chia-Ling Hsieh, Zhihui Xie, Jie Yu, et al.
The Prostate
|
March 8, 2007
IRL-1620, a tumor selective vasodilator, augments the uptake and efficacy of chemotherapeutic agents in prostate tumor rats
N V Rajeshkumar, George Matwyshyn, Anil Gulati
The Prostate
|
January 1, 1992
Evidence for a non-estrogenic cytostatic effect of estramustine on human prostatic carcinoma cells in vivo
S Eklöv, S Nilsson, A Larson, et al.
Page
of 609
Search research articles
Search
Showing results (151-160 of 6,083) with videos related to
Sort By:
Page
of 609
The Prostate
|
December 14, 2006
BXL-628, a vitamin D receptor agonist effective in benign prostatic hyperplasia treatment, prevents RhoA activation and inhibits RhoA/Rho kinase signaling in rat and human bladder
Annamaria Morelli, Linda Vignozzi, Sandra Filippi, et al.
The Prostate
|
March 21, 2007
Suggestive genetic linkage to chromosome 11p11.2-q12.2 in hereditary prostate cancer families with primary kidney cancer
Bo Johanneson, Kerry Deutsch, Laura McIntosh, et al.
The Prostate
|
March 22, 2007
Interleukin-6 undergoes transition from growth inhibitor associated with neuroendocrine differentiation to stimulator accompanied by androgen receptor activation during LNCaP prostate cancer cell progression
Soo Ok Lee, Jae Yeon Chun, Nagalakshmi Nadiminty, et al.
The Prostate
|
March 22, 2007
Characterization of the RSL1-dependent conditional expression system in LNCaP prostate cancer cells and development of a single vector format
Julie Lessard, Sonia Ben Aicha, Andréa Fournier, et al.
The Prostate
|
March 8, 2007
Frequency and number of neuroendocrine tumor cells in prostate cancer: no difference between radical prostatectomy specimens from patients with and without neoadjuvant hormonal therapy
Shinichiro Shimizu, Jiro Kumagai, Yoshinobu Eishi, et al.
The Prostate
|
March 8, 2007
Sonic and desert hedgehog signaling in human fetal prostate development
Guodong Zhu, Haiyen E Zhau, Hui He, et al.
The Prostate
|
March 8, 2007
Non-steroidal antiandrogens act as AF-1 agonists under conditions of high androgen-receptor expression
Hiroaki Fuse, Shigeru Korenaga, Matomo Sakari, et al.
The Prostate
|
March 8, 2007
Non-invasive bioluminescent detection of prostate cancer growth and metastasis in a bigenic transgenic mouse model
Chia-Ling Hsieh, Zhihui Xie, Jie Yu, et al.
The Prostate
|
March 8, 2007
IRL-1620, a tumor selective vasodilator, augments the uptake and efficacy of chemotherapeutic agents in prostate tumor rats
N V Rajeshkumar, George Matwyshyn, Anil Gulati
The Prostate
|
January 1, 1992
Evidence for a non-estrogenic cytostatic effect of estramustine on human prostatic carcinoma cells in vivo
S Eklöv, S Nilsson, A Larson, et al.
Page
of 609